🔎 Trials Near Me

Dachaigh › Leukemia Lymphocytic Cronach › Ohio › Cincinnati

Sgrùdaidhean clionaigeach Leukemia Lymphocytic Cronach ann an Cincinnati, OH

Tha 14 sgrùdaidhean airson Leukemia Lymphocytic Cronach a’ lorg phàirtichean aig làraichean ann agus timcheall air Cincinnati (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • Good Samaritan Hospital - Cincinnati, Cincinnati
  • Oncology Hematology Care Inc-Kenwood, Cincinnati
  • Bethesda North Hospital, Cincinnati
  • agus 3 a bharrachd
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

A’ fastadhÌre 3
  • Saint Elizabeth Healthcare ( Site 0041), Edgewood · 8 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06136559

A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

A’ fastadhÌre 4
  • Oncology Hematology Care Inc, Cincinnati
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07218341

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

A’ fastadhÌre 3
  • University of Cincinnati Medical Center, Cincinnati
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT07648264

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

A’ fastadhÌre 2
  • University of Cincinnati, Cincinnati
  • Oncology Hematology Care, Fairfield · 15 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07221500

A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies

A’ fastadhÌre 1
  • University of Cincinnati, Cincinnati
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 31 Iuch 2026 · NCT06708897

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

A’ fastadhÌre 1
  • University of Cincinnati Medical Center, Cincinnati
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Iuch 2026 · NCT05131022

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

A’ fastadhÌre 2
  • Saint Elizabeth Medical Center Edgewood, Edgewood · 8 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Cèit 2026 · NCT06588478

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

A’ fastadhÌre 1
  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • University of Cincinnati, Cincinnati
Aoisean 13 agus nas sine · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT04771572

Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL

A’ fastadhÌre 2
  • University of Cincinnati, Cincinnati
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Faoi 2026 · NCT07014917

Study of Epcoritamab as a Consolidation Therapy in CLL/SLL

A’ fastadhÌre 2
  • University of Cincinnati, Cincinnati
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Faoi 2026 · NCT07108998

LP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This

A’ fastadhÌre 2
  • University of Cincinnati Medical Center, Cincinnati
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Lùna 2025 · NCT06978088

Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

A’ fastadhÌre 1/2
  • University of Cincinnati, Cincinnati
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Lùna 2022 · NCT04502394

Sgrùdaidhean Leukemia Lymphocytic Cronach ann am bailtean eile

Sgrùdaidhean eile ann an Cincinnati

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.